Welcome to our dedicated page for Mama's Creations SEC filings (Ticker: MAMA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mama's Creations Inc. turns handwritten Italian recipes into a nationwide deli brand, and that scale hides rich data inside every SEC filing. If you're Googling "Mama's Creations SEC filings explained simply," this page delivers. Investors tracking the MAMA ticker need to know how fresh-versus-frozen revenue shifts, why USDA audits affect cost of goods, and when leadership buys stock. Those answers live in quarterly and event-driven reports that can top 200 pages.
Stock Titan’s AI reads each document the moment it hits EDGAR and translates the jargon into clear language. Search results like “understanding Mama's Creations SEC documents with AI” or “Mama's Creations quarterly earnings report 10-Q filing” open to concise summaries, KPI charts, and peer comparisons. Real-time alerts for “Mama's Creations Form 4 insider transactions real-time” flag purchases or sales as they happen, while side-by-side trend views cut through accounting footnotes faster than manual review.
Every disclosure type is mapped to the questions professionals actually ask. Need ingredient cost detail? Click “Mama's Creations annual report 10-K simplified.” Curious about factory upgrades? The “Mama's Creations 8-K material events explained” section highlights capital spend within minutes of filing. Compensation structures appear in “Mama's Creations proxy statement executive compensation,” and ownership moves aggregate under “Mama's Creations insider trading Form 4 transactions” and “Mama's Creations executive stock transactions Form 4.” Prefer a narrative walk-through? The “Mama's Creations earnings report filing analysis” distills quarter-over-quarter margin shifts so you can act quickly. From real-time updates to AI-powered context, this page is the one-stop source for mastering Mama's Creations’ regulatory story.
Form 4 highlight: On 07/07/2025 director Lynn L. Blake reported the acquisition of 4,500 restricted stock units (RSUs) of Mama’s Creations, Inc. (MAMA). Each RSU represents the right to receive one share of common stock.
The RSUs are scheduled to vest in four equal tranches of 1,125 shares on 31 Jul 2025, 31 Oct 2025, 31 Jan 2026 and 30 Apr 2026, subject to standard acceleration or forfeiture provisions.
Following the grant, Blake beneficially owns 17,935 MAMA shares, held directly. No derivative securities were reported.
Implications for investors:
- The filing reflects an increase in insider ownership, potentially signalling alignment with shareholder interests.
- The award size is modest relative to Mama’s total shares outstanding and is unlikely to be materially dilutive.
The SEC Form 4 filed on 07/09/2025 shows that Expensify, Inc. (EXFY) director Ying Liu received an equity award on 07/05/2025.
- 2,128 Class A shares were acquired through immediately-vesting restricted stock units (RSUs) issued under the company’s Non-Employee Director Compensation Program.
- The grant price was $0; it is compensation rather than an open-market purchase.
- Following the award, Liu’s direct beneficial ownership increased to 168,207 Class A shares.
This is a routine director compensation transaction with minimal dilution and no direct impact on operating performance or cash flow, but it modestly strengthens insider alignment with shareholders.
Form 4 filing overview: Liberty 77 Capital L.P. and related entities — including Liberty 77 Fund L.P., Liberty 77 Fund International L.P., Liberty 77 Capital Partners L.P., Liberty Capital L.L.C., STM Partners LLC and Steven T. Mnuchin — reported two open-market purchases of Lionsgate Studios Corp. (Ticker: LION) common shares.
- Transaction dates: 07/07/2025 and 07/09/2025
- Total shares acquired: 572,089
- Weighted-average prices: $5.63 on 07/07/2025 (range $5.59-$5.65) and $5.5876 on 07/09/2025 (range $5.55-$5.60)
- Post-transaction ownership: 37,548,125 common shares held indirectly
- Ownership status: Reporting persons remain 10% owners of the issuer
The Form clarifies that each reporting person disclaims beneficial ownership beyond their pecuniary interest. All shares are held by the Cayman-based Liberty Funds, for which Liberty 77 Capital acts as investment manager. Steven T. Mnuchin is president of STM Partners LLC, which indirectly controls the Liberty Manager and the Liberty Funds.
No derivative securities were reported, and there were no dispositions. The filing does not reference a Rule 10b5-1 trading plan. Signatures are incorporated by reference in Exhibit 99.1 and were dated 07/09/2025.
On July 7 2025, Mama's Creations, Inc. (MAMA) filed a Form 4 showing that director Meghan Henson received an equity award of 4,500 restricted stock units (RSUs). The award will vest in four equal installments of 1,125 shares on July 31 2025, October 31 2025, January 31 2026 and April 30 2026, provided service conditions are met. Each RSU converts into one share of common stock with no exercise price, indicating a compensation grant rather than an open-market purchase.
After the grant, Henson’s total beneficial ownership rose to 21,139 common shares. The filing contains no dispositions, derivative transactions or sale price data. While the award modestly increases insider alignment, it does not inject new cash into the company.
Silexion Therapeutics Corp (SLXN) has filed an amended Form 8-K to clarify timing details surrounding its Nasdaq listing status.
The Nasdaq hearings panel has granted the company continued listing but will transfer the ordinary shares and warrants from the Nasdaq Global Market to the Nasdaq Capital Market as soon as practicable. While the original filing stated the move could occur on 8 July 2025, the amendment notes the exact date remains uncertain.
Silexion also warns it may become non-compliant with Nasdaq Listing Rule 5550(a)(2) (minimum $1.00 bid price) if its shares close below that threshold for 30 straight trading days. Management intends to cure any deficiency through a 1-for-15 reverse share split, subject to shareholder approval at the reconvened AGM on 14 July 2025. After approval, a mandatory 10-day Nasdaq notice period would push the split to roughly 25 July 2025, with compliance only achieved after the stock trades above $1.00 for 10 consecutive days—placing the earliest compliance window in early-to-mid August 2025.
The company cautions that there is no assurance shareholders will approve the split or that the post-split price will meet Nasdaq requirements, leaving a continued risk of delisting.